Inventor · disambiguated record
David Gooden
Also filed as: GOODEN DAVID · GOODEN DAVID M · GOODEN DAVID MARTIN
16 granted patents·11 pending applications·113 citations·filing 2008–2024
92Inventor score
Top patents by PatentIndex Score
27 records- 0197US8795706B2Methods of treating ocular diseases using derivatives of lipoic acidGARNER WILLIAM·Filed 2010·Granted Aug 5, 2014·33 cites·18 claims
- 0297US8410162B2Choline estersGARNER WILLIAM·Filed 2010·Granted Apr 2, 2013·46 cites·26 claims
- 0391US10039743B2Method of treating presbyopia using dithiol compounds and their derivativesENCORE HEALTH LLC·Filed 2016·Granted Aug 7, 2018·5 cites·14 claims
- 0490US9284305B2Methods of treating ocular diseases using derivatives of lipoic acidENCORE HEALTH LLC·Filed 2014·Granted Mar 15, 2016·5 cites·35 claims
- 0590US8383836B2Methods and systems for treating cell proliferation disorders with psoralen derivativesUNIV DUKE·Filed 2010·Granted Feb 26, 2013·6 cites·9 claims
- 0686US8791275B2Methods and systems for treating cell proliferation disorders with psoralen derivativesIMMUNOLIGHT LLC·Filed 2013·Granted Jul 29, 2014·3 cites·14 claims
- 0785US9439897B2Use of psoralen derivatives and combination therapy for treatment of cell proliferation disordersIMMUNOLIGHT LLC·Filed 2015·Granted Sep 13, 2016·6 cites·29 claims
- 0884US8907109B2Methods and systems for treating cell proliferation disorders with psoralen derivativesIMMUNOLIGHT LLC·Filed 2013·Granted Dec 9, 2014·2 cites·9 claims
- 0982US9326970B2Choline estersENCORE HEALTH LLC·Filed 2014·Granted May 3, 2016·3 cites·12 claims
- 1080US9567314B2Dithiol compounds, derivatives, and uses thereforENCORE HEALTH LLC·Filed 2016·Granted Feb 14, 2017·2 cites·13 claims
- 1179US2022151988A1Choline EstersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1273US11452884B2Methods and systems for treating cell proliferation disorders with psoralen derivativesIMMUNOLIGHT LLC·Filed 2018·Granted Sep 27, 2022·1 cites·16 claims
- 1372US2025122209A1Methods and compositions for drugs to treat ophthalmic diseasesUNIV DUKE·Filed 2024·Application pending·0 cites
- 1470US2020352903A1Choline EstersENCORE HEALTH LLC·Filed 2020·Application pending·0 cites
- 1569US9879005B2Composition and methods for the treatment of CaMKK2-mediated disordersUNIV DUKE·Filed 2016·Granted Jan 30, 2018·1 cites·12 claims
- 1664US2018228767A1Choline EstersENCORE HEALTH LLC·Filed 2017·Application pending·0 cites
- 1762US9585850B2Methods of treatment using arylcyclopropylamine compoundsUNIV DUKE·Filed 2014·Granted Mar 7, 2017·0 cites·2 claims
- 1862US2014121266A1Choline EstersGARNER WILLIAM·Filed 2013·Application pending·0 cites
- 1960US12221447B2Methods and compositions for drugs to treat ophthalmic diseasesUNIV DUKE·Filed 2019·Granted Feb 11, 2025·0 cites·18 claims
- 2060US2016287557A1Choline EstersENCORE HEALTH LLC·Filed 2016·Application pending·0 cites
- 2157US10336750B2Composition and methods for the treatment of CaMKK2-mediated disordersUNIV DUKE·Filed 2017·Granted Jul 2, 2019·0 cites·14 claims
- 2253US2013178520A1Methods of treatment using arylcyclopropylamine compoundsUNIV DUKE·Filed 2012·Application pending·0 cites
- 2349US7935847B2Nitroxyl ion source with second order reaction nitroxyl releaseUNIV DUKE·Filed 2008·Granted May 3, 2011·0 cites·16 claims
- 2445US2014343118A1Methods of treatment using arylcyclopropylamine compoundsUNIV DUKE·Filed 2014·Application pending·0 cites
- 2544US2016331731A1Use of psoralen derivatives and combination therapy for treatment of cell proliferation disordersIMMUNOLIGHT LLC·Filed 2016·Application pending·0 cites
- 2639US2018273464A1Synthesis and in vitro activity of d-lactic acid oligomersGOLDBERG JOEL STEVEN·Filed 2018·Application pending·0 cites
- 2736US2017113061A1Methods and systems for treating cell proliferation disorders with psoralen derivativesIMMUNOLIGHT LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Gooden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →